TWD 19.05
(-0.52%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -2.01 TWD | 11.06% |
2022 | -2.26 TWD | -11.88% |
2021 | -2.02 TWD | -51.88% |
2020 | -1.33 TWD | 69.5% |
2019 | -4.36 TWD | 13.83% |
2018 | -5.06 TWD | 10.6% |
2017 | -5.66 TWD | -79.68% |
2016 | -3.15 TWD | -331.51% |
2015 | -0.73 TWD | 75.5% |
2014 | -2.98 TWD | 69.06% |
2013 | -9.63 TWD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.58 TWD | 24.68% |
2024 Q1 | -0.77 TWD | -670.0% |
2023 Q4 | -0.10 TWD | 81.13% |
2023 FY | - TWD | 11.06% |
2023 Q1 | -0.62 TWD | -40.91% |
2023 Q2 | -0.75 TWD | -20.97% |
2023 Q3 | -0.53 TWD | 29.33% |
2022 FY | - TWD | -11.88% |
2022 Q1 | -0.90 TWD | -190.32% |
2022 Q4 | -0.44 TWD | 20.0% |
2022 Q3 | -0.55 TWD | -41.03% |
2022 Q2 | -0.39 TWD | 56.67% |
2021 Q4 | -0.31 TWD | 58.67% |
2021 Q2 | -0.67 TWD | -131.03% |
2021 Q1 | -0.29 TWD | -144.62% |
2021 FY | - TWD | -51.88% |
2021 Q3 | -0.75 TWD | -11.94% |
2020 FY | - TWD | 69.5% |
2020 Q4 | 0.65 TWD | 332.14% |
2020 Q3 | -0.28 TWD | 75.0% |
2020 Q2 | -1.12 TWD | -80.65% |
2020 Q1 | -0.62 TWD | 23.46% |
2019 Q3 | -1.11 TWD | 12.6% |
2019 FY | - TWD | 13.83% |
2019 Q1 | -1.21 TWD | -6.14% |
2019 Q2 | -1.27 TWD | -4.96% |
2019 Q4 | -0.81 TWD | 27.03% |
2018 Q2 | -1.21 TWD | 0.0% |
2018 FY | - TWD | 10.6% |
2018 Q4 | -1.14 TWD | 25.49% |
2018 Q3 | -1.53 TWD | -26.45% |
2018 Q1 | -1.21 TWD | 6.92% |
2017 Q3 | -1.30 TWD | 15.03% |
2017 Q2 | -1.53 TWD | 0.0% |
2017 Q4 | -1.30 TWD | 0.0% |
2017 Q1 | -1.53 TWD | 0.0% |
2017 FY | - TWD | -79.68% |
2016 Q4 | - TWD | 0.0% |
2016 Q2 | -1.18 TWD | 0.0% |
2016 FY | - TWD | -331.51% |
2015 FY | - TWD | 75.5% |
2015 Q4 | - TWD | 0.0% |
2014 FY | - TWD | 69.06% |
2013 FY | - TWD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Excelsior Medical Co., Ltd. | 4.80 TWD | 141.875% |
Apex Medical Corp. | 1.51 TWD | 233.113% |
OK Biotech Co., Ltd. | 0.02 TWD | 8839.13% |